DIO2 Antibody

中文名稱：

DIO2兔多克隆抗體
貨號：

CSB-PA821705LA01HU
規(guī)格：

￥440
圖片：
IHC image of CSB-PA821705LA01HU diluted at 1:400 and staining in paraffin-embedded human skeletal muscle tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.

Immunofluorescence staining of A549 cells with CSB-PA821705LA01HU at 1:133, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) DIO2 Polyclonal antibody
Uniprot No.：

Q92813
基因名：

DIO2
別名：

DIO2; ITDI2; TXDI2; Type II iodothyronine deiodinase; 5DII; DIOII; Type 2 DI; Type-II 5'-deiodinase
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Type II iodothyronine deiodinase protein (74-222AA)
免疫原種屬：

Homo sapiens (Human)

標記方式：

Non-conjugated

本頁面中的產(chǎn)品，DIO2 Antibody (CSB-PA821705LA01HU)，的標記方式是Non-conjugated。對于DIO2 Antibody，我們還提供其他標記。見下表：

標記方式	貨號	產(chǎn)品名稱	應用
HRP	CSB-PA821705LB01HU	DIO2 Antibody, HRP conjugated	ELISA
FITC	CSB-PA821705LC01HU	DIO2 Antibody, FITC conjugated
Biotin	CSB-PA821705LD01HU	DIO2 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產(chǎn)品提供形式：

Liquid
應用范圍：

ELISA, IHC, IF

推薦稀釋比：

Application	Recommended Dilution
IHC	1:200-1:500
IF	1:50-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
Immunofluorescence (IF) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

功能：

Responsible for the deiodination of T4 (3,5,3',5'-tetraiodothyronine) into T3 (3,5,3'-triiodothyronine). Essential for providing the brain with appropriate levels of T3 during the critical period of development.
基因功能參考文獻：
1. adipocyte-derived DIO2 may play a role in weight maintenance but is likely not a major contributor to obesity-related insulin resistance PMID: 30116736
2. Thr92AlaD2 was associated with molecular markers known to underlie Alzheimer disease (AD) pathogenesis in African Americans (AAs), translating to an observed phenotype of increased odds of developing AD/dementia in AAs in these populations. Thr92AlaD2 might represent one factor contributing to racial discrepancies in incident AD. PMID: 29481662
3. In vitro, GH significantly increased D2 expression at the mRNA level in HTC/C3 cells, as well as D2 protein and its activity. GH increased serum fT3 level and decreased serum fT4 level in humans. Our results suggest that its mechanism involves D2 upregulation. PMID: 29274063
4. the low frequency of the TT genotype D2 rs225014 polymorphism was associated with the development of AITD and severity of HD. PMID: 29648895
5. Expression of DIO2 mRNA/protein was reduced in recurrent depressive disorders. PMID: 29367100
6. The Thr92Ala polymorphism of D2 was not associated with thyroid parameters, HRQoL, and cognitive functioning in the general population and in participants on thyroid hormone replacement therapy. PMID: 27786042
7. Thyroidectomized patients carrying DIO2 Thr92Ala are at increased risk of reduced intracellular and serum T3 concentrations that are not adequately compensated for by LT4, thus providing evidence in favor of customized treatment of hypothyroidism in athyreotic patients. PMID: 28324063
8. D2-Thr92Ala genetic variant is associated with the severity and the obstetric outcome of preeclampsia, and it also influences thyroid hormone levels. PMID: 27809617
9. Homozygosity for the Dio2 Thr92Ala polymorphism is associated with higher HbA1C levels in type 2 diabetes patients. [Meta-Analysis] PMID: 27777960
10. the reduction of SAT DIO2 expression is negatively correlated with DBP and TG levels that are associated with the MetS. This might have an effect on developing MetS. PMID: 26588490
11. In subjects who are alcohol dependent, the rs225014 DIO2 gene was associated with significant differences in the amount of naturalistic alcohol drinking. PMID: 26207529
12. Data provide evidence in humans that genetic predisposition combined with early osteoarthritis-related changes results in loff of epigenetic silencing of DIO2. PMID: 24695009
13. DIO2 gene plays a role in the etiology of recurrent depressive disorder.Association of the DIO2 gene single nucleotide polymorphisms with recurrent depressive disorder. PMID: 26098717
14. DIO2 gene polymorphisms may play a role in the incidence of MCI in male patients. PMID: 26125736
15. conversion of T4 to T3 by D2 is required for TRalpha1/PI3K-mediated nongenomic actions of T4 in HUVECs, including stimulation of Akt phosphorylation and Rac activation, which result in cell migration. PMID: 26284425
16. Ala92-D2 accumulates in the Golgi, where its presence and/or ensuing oxidative stress disrupts basic cellular functions and increases pre-apoptosis. PMID: 25569702
17. The rs225017 polymorphism in the 3'UTR of the human DIO2 gene is associated with increased insulin resistance. PMID: 25105294
18. Identification of two heterozygous nonsynonymous mutations in the thyroid hormone activating type 2 deiodinase. PMID: 25140401
19. [review] D2 variants correlate with thyroid hormone levels, insulin resistance, bipolar mood disorder, psychological well-being, mental retardation, hypertension, and risk for osteoarthritis. PMID: 24878678
20. interaction between UbD2 and p97/Atx3 mediates retranslocation of UbD2 to the cytoplasm for terminal degradation in the proteasomes. PMID: 24196352
21. Single Nucleotide Polymorphisms in the genes GPX1 (rs1050450, rs1800668 and rs3811699), TrxR2 (rs5748469), and DIO2 (rs225014) may not be significantly associated with Kashin-Beck disease in a Tibetan population. PMID: 24058403
22. Data suggest posttranslational mechanism via proteasomal degradation (not NFkappaB [nuclear factor-kappa-B] activation) is involved in suppression of DIO2 (type 2 iodothyronine deiodinase) by TNFalpha (tumor necrosis factor-alpha) in thyroid cells. PMID: 23719846
23. Type 2 deiodinase (DIO2) Thr92Ala polymorphism is associated with reduced placental DIO2 activity but not with dysglycemia, increased insulin resistance, or worse gestational outcomes. PMID: 24355051
24. Mutations affecting DIO2 are not a common cause of high BMD in healthy euthyroid post-menopausal women. PMID: 24480136
25. genetic association study in population of women in Italy: Data suggest that an SNP in DIO2 (T92A) is not associated with autoimmune thyroiditis in the population studied. PMID: 23013882
26. DIO2 rs7140952 polymorphism is associated with components of metabolic syndrome including blood pressure and central obesity in hypothyroid patients. PMID: 23329579
27. An association of type 2 deiodinase Thr92Ala polymorphism with frequency of disease development. PMID: 23193417
28. findings demonstrate that upregulated expression of DIO2 in osteoarthritis (OA) patient cartilage might be responsible for OA pathogenesis by enhancing the chondrocyte hypertrophy and inflammatory response. PMID: 23296253
29. Data show that C/EBPalpha and C/EBPbeta promote Dio2 expression in the trophoblastic cell line JEG3 through a conserved CCAAT element, which is a novel key component of the Dio2 promoter code that confers tissue-specific expression of D2 in these cells. PMID: 22689263
30. In osteoarthritis cartilage, D2 protein presence is increased. PMID: 22492780
31. Common polymorphisms in DIO2 subtly affect the circulating levels of thyroid hormone and modulate thyroid hormone homeostasis. PMID: 22307573
32. Data suggest that DIO2 expression is increased in dorsocervical subcutaneous brown adipose tissue among patients with HIV lipodystrophy, particularly those with increased visceral adiposity, and is positively associated with energy expenditure. PMID: 22259052
33. DIO2 modifies inflammatory responses in chondrocytes. PMID: 22353746
34. The DIO2 gene was genotyped by using five haplotype-tagging single-nucleotide polymorphisms (SNPs) in 157 Chinese mental retardation high-density family pedigrees, including 452 nuclear families and >1460 persons. PMID: 22048657
35. Variation in DIO2 may have a subtle role in altering metabolic processes that lead to early-onset NIDDM, but this gene does not have a large impact on NIDDM at older ages, nor does DIO2 influence BMI in the Pima Indian population. PMID: 22142372
36. deiodinase iodothyronine type II is selectively lost during endoplasmic reticulum stress due to an eukaryotic initiation factor 2-mediated decrease in synthesis and sustained proteasomal degradation PMID: 22053000
37. DIO2 is a novel ALI candidate gene, the nonsynonymous Thr92Ala coding variant of which confers ALI protection. Increased DIO2 expression PMID: 21685153
38. Our data suggest that the negative feedback of free T4 on TSH is weaker in patients homozygous for the D2-rs12885300 T allele than in wild-type and heterozygous subjects. PMID: 21715540
39. [REVIEW] discuss the molecular mechanisms by which DIO2 controls intracellular T(3) availability and action PMID: 21292729
40. D2 activity and mRNA are present in the human preadipocytes from both mesenteric and subcutaneous adipose tissue. PMID: 21323585
41. The commonly occurring Thr92Ala D2 variant is associated with a decreased rate of acute TSH-stimulated T3 release from the thyroid consistent with a decrease in intrathyroidal deiodination. PMID: 21054208
42. The D2 Thr92Ala polymorphism is associated with a decreased femoral neck bone mineral density and higher bone turnover. PMID: 20200941
43. Thigh subcutaneous adipose tissue from subjects with familial partial lipodystrophy 2 has higher DIO2 expression of & activity than abdominal SAT, suggesting that changes in local thyroid hormone metabolism may occur in areas with lipoatrophy. PMID: 20373986
44. hDIO2 promoter is down-regulated at the transcriptional level by both LXR and RXR signal pathway. PMID: 20176747
45. Genetic variations of type II deiodinase are associated with bipolar disorder in a subset of a Chinese Han population. PMID: 19427350
46. Type 2 iodothyronine deiodinase expression is upregulated by the protein kinase A-dependent pathway and is downregulated by the protein kinase C-dependent pathway in cultured human thyroid cells. PMID: 11716036
47. The effects of TNF-alpha, interleukin-6 and interferon gamma were studied on the activity of type 2,5'-deiodinase and on the binding of [125I] T(4) to proteins in human thyroid cytosolic (supernatant) and membrane (pellet) fractions PMID: 11716958
48. mutants with a cysteine or serine two-residue amino terminal to the SeC are enzymatically active and displayed similar Michaelis-Menten constant values for T(4) and reverse T(3) as the wild-type D2 enzyme PMID: 11897672
49. The inhibition by D2 5'UTR is localized to a region of the first short open reading frame encoding a tripeptide-MKG PMID: 12089359
50. Ubc6p and Ubc7p are required for normal and substrate-induced ubiquitination and proteolysis of D2 PMID: 12198238
顯示更多

收起更多
亞細胞定位：

Membrane; Single-pass membrane protein.
蛋白家族：

Iodothyronine deiodinase family
組織特異性：

Isoform 1 is expressed in the lung, trachea, kidney, heart, skeletal muscle, placenta, fetal brain and several regions of the adult brain. Isoform 2 is expressed in the brain, heart, kidney and trachea.
數(shù)據(jù)庫鏈接：

HGNC: 2884

OMIM: 601413

KEGG: hsa:1734

UniGene: Hs.202354

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human